Capula Management LTD Abbott Laboratories Call Options Transaction History

Capula Management LTD

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $140,098 - $165,382	-1,400 Reduced 43.75%	1,800 $205,000
Q2 2024 Aug 05, 2024	BUY	$100.73 - $112.44 $322,336 - $359,808	3,200 New	3,200 $332,000
Q3 2023 Nov 03, 2023	BUY	$95.53 - $114.62 $668,710 - $802,340	7,000 New	7,000 $677,000
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $7.77 Million - $9.14 Million	-80,200 Reduced 39.08%	125,000 $12.7 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $11.9 Million - $14 Million	-125,400 Reduced 37.93%	205,200 $22.5 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $32 Million - $37 Million	330,600 New	330,600 $32 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $2.89 Million - $3.54 Million	-25,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $174,990 - $193,590	1,500 Added 6.38%	25,000 $2.94 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $1.84 Million - $2.05 Million	23,500 New	23,500 $2.04 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.